NumberOfSamples: 65 colorectal cancer (CRC) cell lines  
NumberOfSamples: 90 CRC patients  
NumberOfSamples: 1,074 CRC tumours  
CellLine: SW480  
CellLine: C10  
CellLine: CaCo‐2  
CellLine: CC07  
CellLine: HDC‐135  
CellLine: HDC‐143  
CellLine: SK‐CO‐1  
CellLine: T84  
CellLine: RKO  
CellLine: LS 180  
CellLine: HDC‐111  
CellLine: HT55  
CellLine: OXCO‐1  
CellLine: C125‐PM  
Temperature: 37°C  
Temperature: 4°C  
ConcentrationOfCompound: 1% Pen‐Strep  
ConcentrationOfCompound: 100 units/ml  
ConcentrationOfCompound: 100 μg/ml  
ConcentrationOfCompound: 10% foetal bovine serum  
SourceName: SLI EU‐000F Batch 503005  
ReductionReagent: DTT  
ConcentrationOfCompound: 10 mM DTT  
AlkylationReagent: chloroacetamide  
ConcentrationOfCompound: 55 mM chloroacetamide  
CleavageAgent: trypsin  
Instrument: Orbitrap Velos mass spectrometer  
Instrument: Orbitrap Elite mass spectrometer  
Instrument: Dionex Ultimate 3000 HPLC system  
Instrument: Eksigent nanoLC‐Ultra 1D+  
AcquisitionMethod: data‐dependent acquisition  
IonizationType: positive ion mode  
FragmentationMethod: higher‐energy collisional dissociation (HCD)  
CollisionEnergy: 30% normalised collision energy  
PrecursorMassTolerance: 4.5 ppm  
FragmentMassTolerance: 20 ppm  
Separation: reverse‐phase gradient  
FlowRateChromatogram: 300 nl/min  
GradientTime: 96 min  
MS2MassAnalyzer: Orbitrap  
EnrichmentMethod: Kinobeads gamma (KBγ) pulldowns  
AssayName: nanoflow LC‐MS/MS